Skip to main content

OPPENHEIMER ASSET MANAGEMENT INC.

Position in HALO — Halozyme Therapeutics, Inc.

CIK 1269119 NEW YORK, NY

Position in HALO

as of Mar 31, 2026 · filed Apr 24, 2026
Position Value
$1,911,043
-$57,683 QoQ
Shares Held
29,569
+1.1% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0.ToString("F0")% Shared 100.ToString("F0")% None 0.ToString("F0")%

Common Shares in HALO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

OPPENHEIMER ASSET MANAGEMENT INC. holds $55,806,770 across 25 Biotechnology names. HALO ranks #7 (3.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 HALO
Halozyme Therapeutics, Inc.
This page
29,569 $1,911,043

All Filings in HALO

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,911,043 29,569
2025-12-31 $1,968,726 29,253
2025-09-30 $2,281,900 31,114
2025-06-30 $2,106,549 40,495
2025-03-31 $2,668,086 41,813
2024-12-31 $1,999,796 41,828
2024-09-30 $2,854,615 49,871
2024-06-30 $1,356,384 25,905
2024-03-31 $919,245 22,597
2023-12-31 $928,360 25,118
2023-09-30 $1,075,138 28,145
2023-06-30 $1,013,242 28,091
2023-03-31 $1,071,572 28,059
2022-12-31 $2,616,944 45,992
2022-09-30 $1,701,326 43,028
2022-06-30 $1,709,972 38,863
2022-03-31 $1,541,241 38,647
2021-12-31 $1,532,000 38,100
2021-09-30 $1,740,533 42,786
2021-06-30 $1,497,710 32,982
2021-03-31 $1,375,768 33,000
2020-12-31 $977,673 22,891
2020-09-30 $591,457 22,506
2020-06-30 $586,065 21,860
2020-03-31 $61,327 3,409